In this study, we demonstrated a therapeutic potential of BM-MSCs in CCl4-induced rat liver fibrosis through inhibition of IL17A/F isoforms expressed genes and IL17 associated signaling pathway. This evidence concerns the gene IL17A and Hepatic fibrosis.